Strategic Diversification: From COVID to Oncology Innovation After the global success of its COVID-19 vaccine, Pfizer is strategically shifting...
Latest posts
Oncology Breakthroughs: Expanding Beyond Keytruda® Merck’s oncology pipeline is rapidly evolving beyond its flagship immunotherapy, Keytruda®,...